While a research assistant at the Harvard School of Public Health, Ashley performed genetic engineering projects using the CRISPR Cas-9 system. She continues using this gene-editing tool in her current research in Cambridge biotech, CRISPR Tx.
Posters & Publications:
Padalia,Zinkal, Porras, Ashley. "Production of site-specific Allogeneic CD19 CAR-T Cells by CRISPR-Cas9 for B-Cell Malignancies." Society for Immunotherapy of Cancer Conference. Cellular Therapies Poster Session. 9-12 Nov. 2017. National Harbor, MD, USA.
Wang, Huajin. "Seipin Is Required for Converting Nascent to Mature Lipid Droplets." ELife. ELife Sciences Publications, 26 Aug. 2016. Web.<https://elifesciences.org/content/5/e16582>.
Pub Med ID: 27564575